Rowley Law PLLC is investigating potential securities law violations by HemaCare Corporation (OTCMKTS: HEMA) and its board of directors concerning the proposed acquisition of the company by Charles River Laboratories International, Inc. (NYSE: CRL). Stockholders will receive $25.40 per share of HemaCare Corporation common stock that they hold. The transaction is valued at approximately $380 million and is expected to close in the first quarter of 2020.
If you are a stockholder of HemaCare Corporation and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at email@example.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
The submission of this form does not create an attorney-client relationship.